Pre-clinical evaluation of a novel small molecule inhibitor of FLIP in colorectal cancer
Colorectal cancer (CRC) is the third most commonly diagnosed cancer in Northern Ireland. Not only this but CRC also has poor overall survival rates particularly in the advanced disease setting mainly due to drug resistance to standard-of-care chemotherapeutics. One of the mechanisms of drug resistan...
| Main Author: | |
|---|---|
| Published: |
Queen's University Belfast
2017
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.726346 |